首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1603365

轉染技術市場規模、佔有率、成長分析、按產品、按方法、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Transfection Technologies Market Size, Share, Growth Analysis, by Product (Kits, Equipment), By Method (Physical, Biochemical), By Application (Biomedical Research, Therapeutic Delivery), By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月28日 | 出版商:

SkyQuest | 英文 183 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球轉染技術市場規模將為11億美元，從2023年的12億美元成長到2031年的26.9億美元，在預測期間（2024-2031年）預計複合年成長率為9.4%。

由於慢性病盛行率上升和對個人化藥物的需求不斷增加，生物製藥市場正在經歷顯著成長。這項擴張的核心是轉染技術在生物製藥開發和製造中的關鍵作用。基因治療領域正在快速發展，旨在對抗遺傳疾病和癌症，並且越來越依賴病毒傳遞技術來確保標靶基因傳遞。持續的研究和開發產生了創新的轉染試劑、設備和方法，可提高轉染效率，同時最大限度地減少細胞毒性作用並改善細胞遷移。分子和細胞生物學研究活動的活性化推動了這種創新的激增，我敦促您投資用於藥物發現和功能基因組學的轉染技術。競爭格局的特點是主要企業尋求透過卓越的產品性能、可靠性、易用性、定價和客戶環境來使自己脫穎而出。此外，法律規範顯著影響市場動態，特別是在基因治療和臨床應用方面。隨著產業的發展，技術進步、研究投資和監管合規性的相互作用將繼續塑造生物製藥產業的成長軌跡，為整個價值鏈的相關人員帶來廣闊的機會。

市場概況
物理轉染
- 電穿孔
- 基因槍轉染/基因槍
- 顯微注射
- 其他物理轉染方法
基於生物化學的轉染
- 脂轉染
- 磷酸鈣轉染
- 陽離子聚合物轉染
- DEAE-聚葡萄糖轉染
- 磁力輔助轉染
- 樹狀聚合物介導的轉染
基於病毒載體的轉染
共轉染

轉染技術市場規模：依應用/複合年成長率（2024-2031）

市場概況
生物醫學研究
- 基因/蛋白質表現研究
- 癌症研究
- 基因改造模型
實施治療
- 生物製藥
- 電免疫療法
- 化療
蛋白質生產
細胞微陣列

轉染技術市場規模：最終用戶複合年成長率（2024-2031）

市場概況
製藥和生物技術公司
CRO 和 CDMO
學術研究所
其他

轉染技術市場法規/複合年成長率（2024-2031）

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按公司分公司分類的股份分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

Thermo Fisher Scientific Inc.（US）
Bio-Rad Laboratories, Inc.（US）
QIAGEN（Netherlands）
Merck KGaA（Germany）
Sartorius AG（Polyplus）（Germany）
Lonza（Switzerland）
F. Hoffmann-La Roche Ltd（Switzerland）
Agilent Technologies, Inc.（US）
MaxCyte（US）
Revvity（US）
Takara Bio Inc.（Japan）
Promega Corporation（US）
Danaher Corporation（US）
BOC Sciences（US）
RJH BIOSCIENCES（Canada）
Synvolux（Netherlands）
Altogen Biosciences（US）
BioIVT（US）
Incella GmbH（Germany）
InvivoGen（France）

結論和建議

簡介目錄

Product Code: SQMIG15A2450

Global Transfection Technologies Market size was valued at USD 1.10 Billion in 2022 and is poised to grow from USD 1.2 Billion in 2023 to USD 2.69 Billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

The biopharmaceutical market is witnessing significant growth driven by the rising prevalence of chronic diseases and an increasing demand for personalized medicines. Central to this expansion is the pivotal role of transfection technologies in the development and manufacturing of biopharmaceuticals. The gene therapy sector is experiencing rapid advancements aimed at addressing genetic disorders and cancer, with a growing reliance on viral delivery technologies to ensure targeted gene delivery. Continuous research and development are yielding innovative transfection reagents, devices, and methodologies, enhancing transfection efficiency while minimizing cytotoxic effects and improving cell migration. This surge in innovation is fueled by heightened research activity in molecular and cell biology, prompting academic institutions, research laboratories, and pharmaceutical companies to invest in transfection technologies for drug discovery and functional genomics. The competitive landscape is characterized by leading companies striving for differentiation through superior product performance, reliability, user-friendliness, pricing, and customer support. Moreover, regulatory frameworks significantly influence market dynamics, particularly concerning gene therapy and clinical applications. As the industry evolves, the interplay between technological advancements, investment in research, and regulatory compliance will continue to shape the growth trajectory of the biopharmaceutical sector, signaling promising opportunities for stakeholders across the value chain.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transfection Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transfection Technologies Market Segmental Analysis

Global Transfection Technologies Market is segmented by Product, Method, Application, End User and region. Based on Product, the market is segmented into Kits, Equipment. Based on Method, the market is segmented into Physical transfection (Electroporation, Biolistic transfection/ gene guns, Microinjection, Other physical transfection methods), Biochemical-based transfection (Lipofection, Calcium phosphate transfection, Cationic polymer transfection, DEAE-dextran transfection, Magnet-assisted transfection, Dendrimer-mediated transfection), Viral-vector based transfection, Cotransfection. Based on application, the market is segmented into Biomedical research (Gene and protein expression studies, Cancer research, Transgenic models), Therapeutic delivery (Biotherapeutics, Electroimmunotherapy, Electrochemotherapy), Protein production, Cell-based microarrays. Based on end user, the market is segmented into Pharmaceutical and biotechnology companies, CROs and CDMOs, Academic and research institutes, Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Transfection Technologies Market

The Global Transfection Technologies market is significantly driven by the increasing introduction of innovative products. Co-transfection, which entails the simultaneous introduction of multiple nucleic acids into a eukaryotic cell, exemplifies this trend, showcasing a variety of methodologies including the use of plasmid DNA, combinations of siRNA and plasmid DNA, and multiple miRNAs within a single cell. This technique aims to integrate several foreign genes into host cells, facilitating applications such as the creation of viral or hybrid viral constructs that incorporate multiple plasmid DNA segments. Notable examples include the generation of lentivirus utilizing diverse plasmids-transfer, envelope, and packaging vectors-within HEK293 cells, highlighting the potential advancements in gene delivery systems.

Restraints in the Global Transfection Technologies Market

Restraints in the Global Transfection Technologies market include the escalating costs and complexities associated with certain sterilization methods. Techniques that require specialized equipment or proprietary components can be financially burdensome and challenging to execute. The initial investment, combined with ongoing maintenance expenses and the necessity for specialized expertise, may pose significant barriers, particularly for academic researchers and small biotechnology firms that often operate within tight budget constraints. As a result, these financial and operational hurdles can limit access to essential transfection technologies, potentially stifling innovation and progress within the field.

Market Trends of the Global Transfection Technologies Market

The global transfection technologies market is witnessing a significant trend toward the adoption of advanced delivery systems for nucleic acids. Innovations such as lipid nanoparticles, polymer-based carriers, and viral vectors are increasingly preferred due to their superior transfection efficiency, enhanced cellular targeting, and minimized cytotoxic effects compared to traditional methods. This shift is particularly evident in sectors such as gene therapy, drug delivery, and genome editing, where precision and safety are paramount. The ongoing research in biomedical applications underscores the urgency to design effective viral technologies, signaling a robust demand that is reshaping the landscape of transfection technologies worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Macro-Economic Indicators
Market Attractiveness Index

Global Transfection Technologies Market Size by Product & CAGR (2024-2031)

Market Overview
Kits
Equipment

Global Transfection Technologies Market Size by Method & CAGR (2024-2031)

Market Overview
Physical transfection
- Electroporation
- Biolistic transfection/ gene guns
- Microinjection
- Other physical transfection methods
Biochemical-based transfection
- Lipofection
- Calcium phosphate transfection
- Cationic polymer transfection
- DEAE-dextran transfection
- Magnet-assisted transfection
- Dendrimer-mediated transfection
Viral-vector based transfection
Cotransfection

Global Transfection Technologies Market Size by Application & CAGR (2024-2031)

Market Overview
Biomedical research
- Gene and protein expression studies
- Cancer research
- Transgenic models
Therapeutic delivery
- Biotherapeutics
- Electroimmunotherapy
- Electrochemotherapy
Protein production
Cell-based microarrays.

Global Transfection Technologies Market Size by End User & CAGR (2024-2031)

Market Overview
Pharmaceutical and biotechnology companies
CROs and CDMOs
Academic and research institutes
Other

Global Transfection Technologies Market Size & CAGR (2024-2031)

North America, (Product, Method, Application, End User)
- US
- Canada
Europe, (Product, Method, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Method, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Method, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Method, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Polyplus) (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MaxCyte (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BOC Sciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RJH BIOSCIENCES (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synvolux (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altogen Biosciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioIVT (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Incella GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InvivoGen (France)
- Conclusio Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments